Island Pharmaceuticals (ASX:ILA) FCF Yield % : -8.38 (As of Mar. 23, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Island Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Island Pharmaceuticals's Trailing 12-Month Free Cash Flow is A$-2.89 Mil, and Market Cap is A$34.50 Mil. Therefore, Island Pharmaceuticals's FCF Yield % for today is -8.38%.

The historical rank and industry rank for Island Pharmaceuticals's FCF Yield % or its related term are showing as below:

ASX:ILA' s FCF Yield % Range Over the Past 10 Years
Min: -53.93 Med: -25.96 Max: -7.81
Current: -8.38

During the past 4 years, the highest FCF Yield % of Island Pharmaceuticals was -7.81%. The lowest was -53.93%. And the median was -25.96%.

ASX:ILA's FCF Yield % is ranked better than
59.65% of 1502 companies
in the Biotechnology industry
Industry Median: -14.29 vs ASX:ILA: -8.38

Island Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

Island Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Island Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Island Pharmaceuticals FCF Yield % Chart

Island Pharmaceuticals Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

FCF Yield %

-4.14

-15.94

-34.97

-32.42

Island Pharmaceuticals Semi-Annual Data
	Jun20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
FCF Yield %	Get a 7-Day Free Trial				-17.63	-35.62	-35.00	-37.17	-6.96

Competitive Comparison of Island Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Island Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Island Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Island Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Island Pharmaceuticals's FCF Yield % falls into.

Island Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Island Pharmaceuticals's FCF Yield % for the fiscal year that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-3.165	/	9.761059
	=	-32.42%

Island Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-1.075	*	2	/	30.87149
	=	-6.96%

Island Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Island Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Island Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Island Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Island Pharmaceuticals Ltd (ASX:ILA) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/- Bio101 Financial Advisory Pty Ltd, 697 Burke Road, Suite 201, Camberwell, Melbourne, VIC, AUS, 3124

Website

https://www.islandpharmaceuticals.com

Island Pharmaceuticals Ltd is a drug research and repurposing company focused on developing preventative or therapeutic drugs for viral infections. Its drug candidate ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and another mosquito (or vector) borne diseases. The company carries out its research and development activities principally in the geographic regions of Australia and the United States of America.

Island Pharmaceuticals Headlines

No Headlines